Mason Trebony
Internal Medicine · Moultrie, GANPI 1407825359
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Merz North America, Inc. at 27.4% of the total. Reporting peaked in 2019 at $1,851 and has fallen 97.3% since, to $50 in 2023.
Across 133 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$706
- AstraZeneca$368
- Novo Nordisk$276
- Boehringer Ingelheim$217
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$173
- Takeda Pharmaceuticals U.S.A., Inc.$129
- plus $707 from 15 others
What the payments were for
- Food & beverage$2,570100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 5 | $706 |
| AstraZeneca | 23 | $368 |
| Novo Nordisk | 15 | $276 |
| Boehringer Ingelheim | 11 | $217 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $129 |
| Johnson & Johnson | 11 | $119 |
| Pfizer | 13 | $113 |
| Novartis | 7 | $106 |
| Amgen | 5 | $87 |
| Arbor Pharmaceuticals, Inc. | 4 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| AbbVie(2 entities) | 2 | $27 |
| Merck | 2 | $24 |
| Avanir Pharmaceuticals, Inc. | 2 | $24 |
| Lilly USA, LLC | 2 | $23 |
| Portola Pharmaceuticals, LLC | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$636
How this compares
$2,576 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Moultrie
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.